20
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.987
Exchange
XHKG - Hong Kong Exchange
9 %
Last period ROIC
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Simcere Pharmaceutical
Company Analysis
2096.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2096.HK financial analysis by Eyestock methodology
Valuation
2096.HK valuation using historical relative method
Statements
2096.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2096.HK dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Simcere Pharmaceutical`s ROIC for the last twelve months ended 2023-12-31 is 9 %
